Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
2.
Eur J Pediatr ; 160(6): 382-4, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11421421

ABSTRACT

UNLABELLED: We present the case of an 8-month-old boy with failure to thrive and hypoalbuminaemia due to protein malnutrition caused by the replacement of milk by a rice drink. All symptoms resolved with an appropriate feeding. CONCLUSION: Rice drinks are no alternatives to infant milk formulas and carry a serious risk for the development of protein malnutrition.


Subject(s)
Failure to Thrive/etiology , Infant Food/adverse effects , Protein-Energy Malnutrition/etiology , Diet, Vegetarian , Humans , Infant , Infant Food/analysis , Male
3.
Pediatr Res ; 42(1): 87-92, 1997 Jul.
Article in English | MEDLINE | ID: mdl-9212042

ABSTRACT

Preterm newborns have low serum thyroxine (T4) levels compared with late-gestational fetuses. Low thyroid hormone levels are associated with increased severity of neonatal illness and neurodevelopmental dysfunction. We assessed the endocrine and clinical effects of increasing serum T4 levels in preterm newborns with a gestational age <31 wk. Forty newborns were randomized in a double blind protocol: 20 infants received a daily dose of 20 microg/kg L-T4 for 2 wk, whereas 20 control infants received saline. Serum concentrations of T4, triiodothyronine (T3), reverse T3 (rT3), thyroglobulin (TG), and TSH were measured weekly as well as serum levels of GH, prolactin, and IGF-I. After 2 wk, a TSH-releasing hormone (TRH) test was performed. Neonatal illness and outcome was evaluated by noting heart rate, oxygen requirement, duration of ventilation, development of chronic lung disease, oral fluid intake, and weight gain; a Bayley score was done at the corrected age of 7 mo. L-T4 administration induced a marked increase in serum T4 without apparent change in T3 levels, whereas the postnatal decline in serum rT3 was more gradual. L-T4 treatment was associated with a decrease in serum TG and TSH levels. TRH injection induced a definite rise in serum TSH and T3 in controls, but not in L-T4 treated newborns. Neither L-T4 treatment, nor TRH administration appeared to alter circulating levels of prolactin, GH, or IGF-I. In contrast to the pronounced endocrine effects, no clinical effects of L-T4 administration were detected.


Subject(s)
Infant, Premature/blood , Thyroxine/blood , Thyroxine/therapeutic use , Dopamine/therapeutic use , Double-Blind Method , Female , Human Growth Hormone/blood , Humans , Hypothyroidism/blood , Hypothyroidism/drug therapy , Infant, Newborn , Insulin-Like Growth Factor I/metabolism , Male , Prolactin/blood , Thyroglobulin/blood , Thyrotropin/blood , Thyrotropin-Releasing Hormone , Thyroxine/deficiency , Triiodothyronine/blood , Triiodothyronine, Reverse/blood
SELECTION OF CITATIONS
SEARCH DETAIL